A marketing application is judged on the strength of its scientific evidence. But regulators can only evaluate that evidence when it has been translated into a complete, technically compliant, internally consistent, and navigable application. That is why a complete dossier...
Liz Narciso
Recent regulatory developments are reshaping how sponsors think about evidence, oversight, and operational readiness. In a New England Journal of Medicine Sounding Board, FDA leadership announced that one adequate and well-controlled clinical trial — supported by confirmatory evidence — could become the...